Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2003
07/22/2003US6596850 Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
07/22/2003US6596849 Monoclonal antibody for use in the treatment of cell proliferative disorders
07/22/2003US6596541 Genetically engineering preferential immunoglobulins in cells; obtain cells, transform with vector containing genetically engineered immunoglobulin, recover transformed cells, propagate, recover immunoglobulin
07/22/2003US6596503 Diagnosing cancer in humans; obtain tissue sample, incubate with monoclonal antibody, determine presence of antibody-antigen complex, amplified levels of antigen indicates cancer
07/22/2003US6596498 Bone stimulating factor
07/22/2003US6596497 Screening of antiviral compounds targeted to the HIV-1 gp41 core structure
07/22/2003US6596277 Methods of decreasing cell adhesion
07/22/2003US6596276 Administering antagonist to induced and expressed integrin heterodimers on endothelial cell surface
07/22/2003US6596270 Administering the adenoviral gene transfer vector (exogenous) encoding a gene product to a muscle and the vector is neutralized outside of the muscle by systemic neutralizing antibodies; using a chimeric coat protein for cell entry
07/22/2003CA2329473C Dna encoding prostaglandin receptor ep1
07/22/2003CA2109320C Peptide nucleic acids
07/17/2003WO2003058248A2 Diagnostics and vaccines for mycrobacterium paratuberculosis infections
07/17/2003WO2003057919A2 The use of histamine h4 receptor antagonist for the treatment of inflammatory response
07/17/2003WO2003057906A1 A new vector for genetically modifying non-human animals
07/17/2003WO2003057881A1 Method of stabilizing protein
07/17/2003WO2003057857A2 Antibodies directed to pdgfd and uses thereof
07/17/2003WO2003057854A2 Novel proteins and nucleic acids encoding same
07/17/2003WO2003057838A2 Antibodies against the muc18 antigen
07/17/2003WO2003057837A2 Methods for using anti-muc18 antibodies
07/17/2003WO2003057833A2 Mutant chromophores/fluorophores and methods for making and using the same
07/17/2003WO2003057829A2 Methods of generating multispecific, multivalent agents from vh and vl domains
07/17/2003WO2003057827A2 Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes
07/17/2003WO2003057733A1 Antibodies against fibroblast growth factor 23
07/17/2003WO2003057732A2 Multispecific binding molecules
07/17/2003WO2003057728A1 A novel splice variant of myd88 and uses thereof
07/17/2003WO2003057715A2 Novel ligand involved in the transmigration of leukocytes .
07/17/2003WO2003057252A1 Human mast cell-expressed membrane proteins
07/17/2003WO2003057251A1 Remedies for arthritis
07/17/2003WO2003057250A1 Cancer treatment
07/17/2003WO2003057243A1 Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders
07/17/2003WO2003057238A1 Agents that recognize src when phosphorylated at serine 17
07/17/2003WO2003057178A2 Viral capsid assembly intermediates
07/17/2003WO2003057168A2 Cancer-associated epitope
07/17/2003WO2003057163A2 Methods for preparing immunoconjugates
07/17/2003WO2003057160A2 Compositions and methods for the diagnosis and treatment of tumor
07/17/2003WO2003057155A2 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor
07/17/2003WO2003057146A2 Novel compositions and methods for cancer
07/17/2003WO2003057134A2 Specific binding agents of human angiopoietin-2
07/17/2003WO2003057130A2 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
07/17/2003WO2003057014A2 Biomarkers for detecting ovarian cancer
07/17/2003WO2003057006A2 Use of antibodies against the muc18 antigen
07/17/2003WO2003056914A1 Methods to engineer mammalian-type carbohydrate structures
07/17/2003WO2003056913A1 Nonhuman model animal lacking the ability to control lymphocyte migration
07/17/2003WO2003035892A3 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods
07/17/2003WO2003031595A3 Molecules for disease detection and treatment
07/17/2003WO2003000896A3 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE
07/17/2003WO2002090566A3 Recombinant tumor specific antibody and use thereof
07/17/2003WO2002083928A3 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
07/17/2003WO2002081646A3 Epitope sequences
07/17/2003WO2002074335A3 Equine herpesvirus vaccine
07/17/2003WO2002072626A3 Novel form of the phgpx protein as a diagnostic marker for male infertility
07/17/2003WO2002072008A3 Method for treating cancer using a33 specific antibodies and chemotherapeutic agents
07/17/2003WO2002066057A3 Methods and compositions for preventing and treating neutrophil-mediated diseases
07/17/2003WO2002059286A3 Adenylate cyclases
07/17/2003WO2002043747A3 Modulation of cell growth by inhibiting binding of kringle 2 domain of plasminogen
07/17/2003WO2002040683A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/17/2003WO2002038803A3 Novel marker for the diagnosis and therapy of tumours
07/17/2003WO2002031134A3 Novel serine protease genes related to dppiv
07/17/2003WO2002029060A9 Hematopoietin receptors hpr1 and hpr2
07/17/2003WO2002026998A3 Hydrolases
07/17/2003US20030135034 Nucleotide sequences coding extracellular membrane proteins; antitumor agents; antiproliferative agents; antiiiflammatory agents; enterotoxins; neuroprotectants
07/17/2003US20030135029 Tumour necrosis factor binding ligands
07/17/2003US20030135028 Human serine protease and serpin polypeptides
07/17/2003US20030135026 Compounds and methods for diagnosis of tuberculosis
07/17/2003US20030135025 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134816 Compound capable of modulating the activity and/or expression of hr44, for use in therapy. Hr44 has been cloned from human retinal tissue
07/17/2003US20030134812 Bladder and lower urinary tract syndromes, particularly, irrative symptoms, and to a method of treating same using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists. The invention further relates to a method of screening compounds
07/17/2003US20030134791 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134785 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134784 A novel gene (designated 83P2H3) and its encoded protein are described. While 83P2H3 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in prostate cancer. 83P2H3 provides a diagnostic and/or theraputic target
07/17/2003US20030134430 Novel amino acid sequences for human caenorhabditis elegans-like protein polypeptides
07/17/2003US20030134386 A fibronectin type III (Fn3) monobody polypeptide consisting of two to six beta -strand domains with a loop region linked between each beta-strand domain, and such polypeptide is capable of binding to a target molecule
07/17/2003US20030134385 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134384 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134383 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134382 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134381 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134380 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134379 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide
07/17/2003US20030134378 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134377 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide
07/17/2003US20030134376 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134375 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134374 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134373 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134372 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide
07/17/2003US20030134370 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134369 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134368 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134367 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134366 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134365 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134364 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134363 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134361 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134360 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134359 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134357 Vectors with DNA encoding pro polypeptides
1 ... 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 ... 1494